EN DE

Xilong Scientific Co (002584) Fair Value & Analysis

Basic Materials · CN · Market cap 5.0B CNY

XS Xilong Scientific Co 002584 · SHE
Price¥8.12
Fair Value¥6.80
Upside-16.3%
Quality45/100
Watch Xilong Scientific Co for free, get notified when fair value or trend changes. Watch for free
Expensive Growth
Loss-making · -1.0% net margin
Low debt · negative free cash flow
Mixed vs. peers (6/11)
Narrow moat 25/100
Evidence: Medium Range ¥4.76 – ¥8.84 Share as image

Fair value as of: Jul 22, 2026

From 8 valuation models · updated 19 days ago

Fair value updated Jul 22, 2026, revised from ¥3.53 to ¥6.80 (+92.6%) since Jun 25, 2026. Share price −18.1% over the past month.

Below-average quality, and screening another 16% overvalued on our models.

What matters now

  • Solid but not exceptional quality (45/100) and above fair value, neither a clear bargain nor a standout compounder.
  • A fairly wide model range (¥4.76 to ¥8.84) leaves room in how you read the outcome.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

¥13.60 ¥4.99 Fair Value ¥6.80 Feb 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 22, 2026.

How to read this chart

60‑month range ¥4.99 – ¥13.60 · fair‑value band ¥4.76 – ¥8.84 · the ¥8.12 price screens above the ¥6.80 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 22, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Xilong Scientific Co (002584) currently trades at ¥8.12, while our model-based Fair Value estimate is ¥6.80, implying the stock looks roughly 16.3% overvalued today. The Quality Score stands at 45/100 (below-average quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).

Over the trailing twelve months, Xilong Scientific Co generated revenue of 7.4B CNY at a net margin of -1.0%. Revenue grew 5.7% year over year. It earns a return on equity of -3.2%. Net debt stands at 398M CNY. Fundamentals as of Jul 22, 2026

Our scenario range runs from ¥4.76 (bear case) to ¥8.84 (bull case); at ¥8.12, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 23% below its 52-week high and 15% above its 52-week low, currently below its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -46% fair-value upside, at -16%, 002584 screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model BearBaseBull Evidence
Highest evidence
ROIC Compounder ¥3.18 ¥3.56 ¥4.14 72
Gordon GGM ¥0.7200 ¥1.43 ¥2.16 70
DDM Multi-Stage ¥0.7200 ¥1.24 ¥1.51 61
All 8 models by family
Earnings-Based
EPV ¥3.18 ¥3.56 ¥3.89 59
Dividend Discount
Gordon GGM ¥0.7200 ¥1.43 ¥2.16 70
DDM Multi-Stage ¥0.7200 ¥1.24 ¥1.51 61
Multiples
EV/EBIT ¥3.86 ¥4.88 ¥5.90 53
EV/EBITDA ¥3.96 ¥5.01 ¥6.06 54
EV/Revenue ¥3.45 ¥4.59 ¥5.73 43
Asset-Based
NCAV (Graham) ¥1.85 ¥2.48 ¥3.71 50
Economic Profit
ROIC Compounder ¥3.18 ¥3.56 ¥4.14 72

Widest divergence: Multiples (¥4.88) versus Dividend Discount (¥1.24). Highest evidence: ROIC Compounder (72).

Key figures & financial health

Revenue (TTM) 7.4B CNY
Revenue growth (YoY) +5.7%
Net margin -1.0%
Return on equity -3.2%
Free cash flow −30.8M CNY FY2025
Operating margin 3.0%
More key figures
EPS (TTM) ¥-0.1200
EPS growth (YoY) +100%
Net debt 398M CNY FY2025

Figures from reported company fundamentals · as of Jul 22, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 45/100

Of which business quality 44 · Market factors (momentum, volatility) 40

Profitability 29
Margins and returns on capital today
Quality Growth 26
Are margins and returns improving?
Cashflow 11
Earnings quality: real cash, not paper profit
Fin. Strength 61
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 62
Calm price path (market factor)
Momentum 36
Price trend over the last 3–12 months (market factor)
52W Momentum 24
Distance to the 52-week high (market factor)
Net Issuance 63
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Xilong Scientific Co., Ltd. researches and develops, manufactures, and sells chemical reagents in China. The company offers chemical reagents, PCB reagents, high purity chemical reagents, food additives, active pharmaceutical, wet electronic chemical, and diagnostic reagents products. It also exports its products.

Full company description

Xilong Scientific Co., Ltd. researches and develops, manufactures, and sells chemical reagents in China. The company offers chemical reagents, PCB reagents, high purity chemical reagents, food additives, active pharmaceutical, wet electronic chemical, and diagnostic reagents products. It also exports its products. The company serves industrial, agriculture, health, environmental protection, teaching, scientific research, biology, life sciences, electronics, military industry, aerospace, coating, printing and cosmetics, medical and health, and other sectors. Xilong Scientific Co., Ltd. was formerly known as Xilong Chemical Co., Ltd. and changed its name to Xilong Scientific Co., Ltd. in December 2015. Xilong Scientific Co., Ltd. was founded in 1983 and is based in Guangzhou, China.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Xilong Scientific Co reported revenue of ¥7.3B in FY2025 versus ¥5.4B in FY2021, a compound +8.0%/yr. Reported net income was −¥75.5M in FY2025.

Growth Quality 13/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Latest Revenue (FY 2025)
7.3B CNY
Latest YoY
−6.2%
Avg. growth/yr (3Y)
+5.8%
Avg. growth/yr (5Y)
+3.3%
Avg. growth/yr (17Y)
+14.2%
Revenue +8.0%/yr
FY21 ¥5.4B
FY22 ¥6.2B
FY23 ¥7.1B
FY24 ¥7.8B
FY25 ¥7.3B
Net income
FY21 ¥187M
FY22 ¥89.1M
FY23 ¥33.3M
FY24 ¥61.8M
FY25 −¥75.5M

002584 screens 16% overvalued. Compare with BASF SE →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Xilong Scientific Co Fair Value". https://www.fairvalue-calculator.com/stock/002584

Peer Group

Chemicals · 334 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 45 · Below median
Fair Value upside −16% · Above median
Return on assets 2% · Below median
Net margin (TTM) -1% · Bottom 25%
Operating margin (TTM) 3% · Below median
Revenue growth 6% · Above median
Debt / equity 0.11× · Lower than median

Valuation Multiples vs Chemicals median · lower = cheaper

P/B 0.34× · Cheaper than 75% of peers
P/S (TTM) 0.10× · Cheaper than 75% of peers
EV/EBITDA 1.4× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 12 · sector 0
FUTURE 29 · sector 20
PAST 0 · sector 19
HEALTH 94 · sector 94
DIVIDEND 0 · sector 27

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 22, 2026).

Stock Price Fair Value vs Fair Value
BASF SE BASN 1,034 MXN 532.13 MXN -49%
Ningxia Baofeng Energy Group 600989 ¥20.32 ¥20.17 -1%
Zhejiang Juhua Co 600160 ¥42.85 ¥23.35 -46%
PT Barito Pacific Tbk, BRPT 1,690 IDR 1,628 IDR -4%
LG Chem, Ltd 051910 260,500 KRW 587,755 KRW +126%
Formosa Chemicals & Fibre Corporation 1326 66.10 TWD 6.79 TWD -90%
PTT Global Chemical Public Company PTTGC 35.50 THB 18.21 THB -49%
542812 542812 ₹4,369 ₹791.05 -82%
Indorama Ventures Public Company IVL 24.50 THB 17.95 THB -27%
Navin Fluorine International Limited NAVINFLUOR ₹8,650 ₹2,146 -75%

Compare Xilong Scientific Co with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Xilong Scientific Co (002584) overvalued or undervalued?
As of Jul 22, 2026, our model estimates a fair value of ¥6.80 versus a price of ¥8.12, about −16% (overvalued).
What is the fair value of 002584?
Our model-based fair value for Xilong Scientific Co is ¥6.80 (as of Jul 22, 2026), built from audited fundamentals. The current price is ¥8.12.
What is the quality score of 002584?
Xilong Scientific Co has a Quality Score of 45/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Xilong Scientific Co (002584)?
Xilong Scientific Co reported trailing-twelve-month revenue of about 7.4B CNY (latest available figure, as of Jul 22, 2026).
What is the net profit margin of 002584?
The net profit margin of Xilong Scientific Co is about -1.0%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Xilong Scientific Co and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.